Breast and Gynecologic Cancer Clinical Trials

Titlesort descending Intervention NCT ID Sponsor Status
4-Hydroxytamoxifen or Tamoxifen Citrate in Treating Women With Newly Diagnosed Ductal Breast... oral placebo, afimoxifene, tamoxifen citrate, placebo gel NCT00952731 Northwestern University Completed
Acolbifene in Preventing Cancer in Premenopausal Women at High Risk of Breast Cancer acolbifene hydrochloride NCT00853996 University of Kansas Medical Center Completed
Afimoxifene in Reducing the Risk of Breast Cancer in Women With Mammographically Dense Breast Afimoxifene, Laboratory Biomarker Analysis, Placebo, Questionnaire Administration NCT03063619 M.D. Anderson Cancer Center Recruiting
Alternative Dosing of Exemestane Before Surgery in Treating Postmenopausal Patients With Stage 0-II... Exemestane, Laboratory Biomarker Analysis, Pharmacological Study, Placebo, Quality-of-Life Assessment, Questionnaire Administration, Therapeutic Conventional Surgery NCT02598557 National Cancer Institute (NCI) Recruiting
A Phase I Prevention Study of Atorvastatin in Women at Increased Risk for Breast Cancer atorvastatin calcium, laboratory biomarker analysis NCT00637481 National Cancer Institute (NCI) Completed
Bexarotene in Preventing Breast Cancer in Patients at High Risk for Breast Cancer Bexarotene, Laboratory Biomarker Analysis, Questionnaire Administration NCT03323658 National Cancer Institute (NCI) Recruiting
Defined Green Tea Catechin Extract in Treating Women With Hormone Receptor Negative Stage I-III... placebo, quality-of-life assessment, questionnaire administration, laboratory biomarker analysis, defined green tea catechin extract NCT00516243 National Cancer Institute (NCI) Completed
Exemestane in Treating Patients With Complex Atypical Hyperplasia of the Endometrium/Endometrial... Exemestane, Laboratory Biomarker Analysis, Pharmacological Study, Questionnaire Administration NCT03300557 National Cancer Institute (NCI) Recruiting
Genistein in Preventing Breast Cancer in Women at High Risk for Breast Cancer placebo, genistein, laboratory biomarker analysis NCT00290758 National Cancer Institute (NCI) Completed
Green Tea Extract in Preventing Cervical Cancer in Patients With Human Papillomavirus and Low-Grade... placebo, defined green tea catechin extract, laboratory biomarker analysis NCT00303823 National Cancer Institute (NCI) Completed